Glivec in chronic myeloid leukemia - achievements, failures, problems

被引：0
作者：
Volkova, MA [1 ]
机构：
[1] NN Blokhin Oncol Res Ctr, Moscow, Russia
来源：
GEMATOLOGIYA I TRANSFUZIOLOGIYA | 2004年 / 49卷 / 02期
关键词：
chronic myeloid leukemia; glivec; leukemic cells; BCR-ABL gene;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：35 / 41
页数：7
相关论文
共 41 条
  • [1] UK MEDICAL-RESEARCH-COUNCIL RANDOMIZED, MULTICENTER TRIAL OF INTERFERON-ALPHA-N1 FOR CHRONIC MYELOID-LEUKEMIA - IMPROVED SURVIVAL IRRESPECTIVE OF CYTOGENETIC RESPONSE
    ALLAN, NC
    RICHARDS, SM
    SHEPHERD, PCA
    [J]. LANCET, 1995, 345 (8962) : 1392 - 1397
  • [2] Branford S, 2002, BLOOD, V100, p96A
  • [3] Cortes JE, 2002, BLOOD, V100, p164A
  • [4] Chronic myelogenous leukemia: A review
    Cortes, JE
    Talpaz, M
    Kantarjian, H
    [J]. AMERICAN JOURNAL OF MEDICINE, 1996, 100 (05) : 555 - 570
  • [5] COUTRE P, 2002, BLOOD CELL MOL DIS, V28, P75
  • [6] Druker B.J, 2002, P AN M AM SOC CLIN, V21, P1
  • [7] Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome.
    Druker, BJ
    Sawyers, CL
    Kantarjian, H
    Resta, DJ
    Reese, SF
    Ford, JM
    Capdeville, R
    Talpaz, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) : 1038 - 1042
  • [8] Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
    Druker, BJ
    Tamura, S
    Buchdunger, E
    Ohno, S
    Segal, GM
    Fanning, S
    Zimmermann, J
    Lydon, NB
    [J]. NATURE MEDICINE, 1996, 2 (05) : 561 - 566
  • [9] Gardembas M, 2002, BLOOD, V100, p95A
  • [10] GATELY K, 2002, HEMATOL J 1, V3, P296
12345